 |
PDBsum entry 2jdf
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Structural protein
|
PDB id
|
|
|
|
2jdf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Structural protein
|
 |
|
Title:
|
 |
Human gamma-b crystallin
|
|
Structure:
|
 |
Gamma crystallin b. Chain: a. Synonym: gamma-b crystallin, gamma crystallin 1-2. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.70Å
|
R-factor:
|
0.196
|
R-free:
|
0.220
|
|
|
Authors:
|
 |
H.Ebersbach,E.Fiedler,T.Scheuermann,M.Fiedler,M.T.Stubbs,C.Reimann, G.Proetzel,R.Rudolph,U.Fiedler
|
Key ref:
|
 |
H.Ebersbach
et al.
(2007).
Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein.
J Mol Biol,
372,
172-185.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Jan-07
|
Release date:
|
24-Jul-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P07316
(CRGB_HUMAN) -
Gamma-crystallin B from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
175 a.a.
176 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
372:172-185
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein.
|
|
H.Ebersbach,
E.Fiedler,
T.Scheuermann,
M.Fiedler,
M.T.Stubbs,
C.Reimann,
G.Proetzel,
R.Rudolph,
U.Fiedler.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The concept of novel binding proteins as an alternative to antibodies has
undergone rapid development and is now ready for practical use in a wide range
of applications. Alternative binding proteins, based on suitable scaffolds with
desirable properties, are selected from combinatorial libraries in vitro. Here,
we describe an approach using a beta-sheet of human gamma-B-crystallin to
generate a universal binding site through randomization of eight solvent-exposed
amino acid residues selected according to structural and sequence analyses.
Specific variants, so-called Affilin, have been isolated from a phage display
library against a variety of targets that differ considerably in size and
structure. The isolated Affilin variants can be produced in Escherichia coli as
soluble proteins and have a high level of thermodynamic stability. The crystal
structures of the human wild-type gamma-B-crystallin and a selected Affilin
variant have been determined to 1.7 A and 2.0 A resolution, respectively.
Comparison of the two molecules indicates that the human gamma-B-crystallin
tolerates amino acid exchanges with no major structural change. We conclude that
the intrinsically stable and easily expressed gamma-B-crystallin provides a
suitable framework for the generation of novel binding molecules.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. A representation of bovine γ-B-crystallin used to
model the human γ-B-crystallin scaffold, showing the C^α trace
in cartoon representation and the accessible surface area. The
eight selected amino acid residues (positions 2, 4, 6, 15, 17,
19, 36, and 38) used for library construction are highlighted in
red. This Figure was generated using pdb entry 1AMM and the
program PyMol [http://pymol.sourceforge.net/].
|
 |
Figure 9.
Figure 9. Superposition of all C^α backbones (right) and of
the N-terminal domain (left) of the crystal structure of human
wild-type γ-B-crystallin (red) and of the IgG-Fc binding
Affilin molecule SPC-1-G3 (blue). The superposition was
performed using the program PyMol with rms values of 0.284
Å (N-terminal domain) [http://pymol.sourceforge.net].
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2007,
372,
172-185)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Kapoor,
B.Singh,
K.Subramanian,
and
P.Guptasarma
(2009).
Creation of a new eye lens crystallin (Gambeta) through structure-guided mutagenic grafting of the surface of betaB2 crystallin onto the hydrophobic core of gammaB crystallin.
|
| |
FEBS J,
276,
3341-3353.
|
 |
|
|
|
|
 |
M.Gebauer,
and
A.Skerra
(2009).
Engineered protein scaffolds as next-generation antibody therapeutics.
|
| |
Curr Opin Chem Biol,
13,
245-255.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |